Cargando…

lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis

INTRODUCTION: Our work was aimed to explore the mechanisms of MAGI2 antisense RNA 3 (MAGI2-AS3) in regulating hepatocellular carcinoma (HCC) carcinogenesis. METHODS: MAGI2-AS3, microRNA-519c-3p (miR-519c-3p), and thioredoxin interacting protein (TXNIP) levels in HCC were detected by the RT-qPCR meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Huamei, Tang, Qianli, Wang, Anmin, Zhang, Ya, Qin, Zebang, Li, Wenchuan, Xu, Zuoming, Wang, Jianchu, Pu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416383/
https://www.ncbi.nlm.nih.gov/pubmed/34484334
http://dx.doi.org/10.1155/2021/5547345
_version_ 1783748168631975936
author Wei, Huamei
Tang, Qianli
Wang, Anmin
Zhang, Ya
Qin, Zebang
Li, Wenchuan
Xu, Zuoming
Wang, Jianchu
Pu, Jian
author_facet Wei, Huamei
Tang, Qianli
Wang, Anmin
Zhang, Ya
Qin, Zebang
Li, Wenchuan
Xu, Zuoming
Wang, Jianchu
Pu, Jian
author_sort Wei, Huamei
collection PubMed
description INTRODUCTION: Our work was aimed to explore the mechanisms of MAGI2 antisense RNA 3 (MAGI2-AS3) in regulating hepatocellular carcinoma (HCC) carcinogenesis. METHODS: MAGI2-AS3, microRNA-519c-3p (miR-519c-3p), and thioredoxin interacting protein (TXNIP) levels in HCC were detected by the RT-qPCR method. Cell proliferation and apoptosis rate were measured using Cell Counting Kit-8 assay and flow cytometry assay. Relationship between MAGI2-AS3, TXNIP, and miR-519c-3p were analyzed via luciferase activity assay, RNA pull-down assay, and RNA immunoprecipitation assay. Mouse xenograft models of HCC were conducted to explore the roles of MAGI2-AS3 in vivo. RESULTS: MAGI2-AS3 levels were elevated, and miR-519c-3p decreased in HCC. MAGI2-AS3 overexpression inhibits while its knockdown stimulates HCC cell growth through miR-519c-3p. Moreover, miR-519c-3p overexpression stimulates HCC cell growth. MAGI2-AS3 serves as competing endogenous RNA (ceRNA) of miR-519c-3p to regulate TXNIP in HCC. And, TXNIP upregulation weakened the influence of MAGI2-AS3 knockdown on HCC cell behaviors. Additionally, MAGI2-AS3 overexpression suppressed HCC tumor growth in vivo. CONCLUSION: MAGI2-AS3 inhibits HCC tumorigenesis through miR-519c-3p/TXNIP axis in vitro and in vivo, indicating MAGI2-AS3 plays a crucial role in HCC development.
format Online
Article
Text
id pubmed-8416383
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-84163832021-09-04 lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis Wei, Huamei Tang, Qianli Wang, Anmin Zhang, Ya Qin, Zebang Li, Wenchuan Xu, Zuoming Wang, Jianchu Pu, Jian J Oncol Research Article INTRODUCTION: Our work was aimed to explore the mechanisms of MAGI2 antisense RNA 3 (MAGI2-AS3) in regulating hepatocellular carcinoma (HCC) carcinogenesis. METHODS: MAGI2-AS3, microRNA-519c-3p (miR-519c-3p), and thioredoxin interacting protein (TXNIP) levels in HCC were detected by the RT-qPCR method. Cell proliferation and apoptosis rate were measured using Cell Counting Kit-8 assay and flow cytometry assay. Relationship between MAGI2-AS3, TXNIP, and miR-519c-3p were analyzed via luciferase activity assay, RNA pull-down assay, and RNA immunoprecipitation assay. Mouse xenograft models of HCC were conducted to explore the roles of MAGI2-AS3 in vivo. RESULTS: MAGI2-AS3 levels were elevated, and miR-519c-3p decreased in HCC. MAGI2-AS3 overexpression inhibits while its knockdown stimulates HCC cell growth through miR-519c-3p. Moreover, miR-519c-3p overexpression stimulates HCC cell growth. MAGI2-AS3 serves as competing endogenous RNA (ceRNA) of miR-519c-3p to regulate TXNIP in HCC. And, TXNIP upregulation weakened the influence of MAGI2-AS3 knockdown on HCC cell behaviors. Additionally, MAGI2-AS3 overexpression suppressed HCC tumor growth in vivo. CONCLUSION: MAGI2-AS3 inhibits HCC tumorigenesis through miR-519c-3p/TXNIP axis in vitro and in vivo, indicating MAGI2-AS3 plays a crucial role in HCC development. Hindawi 2021-08-27 /pmc/articles/PMC8416383/ /pubmed/34484334 http://dx.doi.org/10.1155/2021/5547345 Text en Copyright © 2021 Huamei Wei et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wei, Huamei
Tang, Qianli
Wang, Anmin
Zhang, Ya
Qin, Zebang
Li, Wenchuan
Xu, Zuoming
Wang, Jianchu
Pu, Jian
lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis
title lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis
title_full lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis
title_fullStr lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis
title_full_unstemmed lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis
title_short lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis
title_sort lncrna magi2-as3 exerts antioncogenic roles in hepatocellular carcinoma via regulating the mir-519c-3p/txnip axis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416383/
https://www.ncbi.nlm.nih.gov/pubmed/34484334
http://dx.doi.org/10.1155/2021/5547345
work_keys_str_mv AT weihuamei lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis
AT tangqianli lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis
AT wanganmin lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis
AT zhangya lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis
AT qinzebang lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis
AT liwenchuan lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis
AT xuzuoming lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis
AT wangjianchu lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis
AT pujian lncrnamagi2as3exertsantioncogenicrolesinhepatocellularcarcinomaviaregulatingthemir519c3ptxnipaxis